![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KA Wafford, M Kathoria, CJ Bain, G Marshall, B Le Bourdelles, JA Kemp and PJ Whiting
Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, Essex, UK.
The mammalian N-methyl-D-aspartate (NMDA) receptor complex is though to consist of an NR1 subunit in combination with one or more of the four NR2 subunits (A, B, C, and D). When corresponding cDNAs are expressed in Xenopus oocytes, ion channels with the characteristic profile of NMDA receptors are formed. The receptor is unique in requiring two coagonists, glutamate and glycine, for activation of the channel. We have used site-directed mutagenesis to study amino acids in the human NR1 subunit that contribute to the glycine binding site of the NMDA receptor without affecting the agonist site for glutamate. Mutations to D481 and K483 produced receptors with up to 160-fold lower affinities for glycine, as well as other agonists and partial agonists, without affecting maximum current size or the degree of agonist efficacy. The D481A mutation also led to 40-50-fold lower affinities for two structurally diverse glycine site antagonists. From these data we propose that the carboxyl group of this aspartate interacts with the amino moiety of glycine and the equivalent group contained in other agonists and antagonists.
This article has been cited by other articles:
|
|
 |
|
  P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 227 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Smothers and J. J. Woodward Pharmacological Characterization of Glycine-Activated Currents in HEK 293 Cells Expressing N-Methyl-D-aspartate NR1 and NR3 Subunits J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 739 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yao and M. L. Mayer Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. J. Neurosci., April 26, 2006; 26(17): 4559 - 4566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li, T. H. Murphy, M. R. Hayden, and L. A. Raymond Enhanced Striatal NR2B-Containing N-Methyl-D-Aspartate Receptor-Mediated Synaptic Currents in a Mouse Model of Huntington Disease J Neurophysiol, November 1, 2004; 92(5): 2738 - 2746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Kalbaugh, H. M. A. VanDongen, and A. M. J. VanDongen Ligand-Binding Residues Integrate Affinity and Efficacy in the NMDA Receptor Mol. Pharmacol., August 1, 2004; 66(2): 209 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Simeone, R. M. Sanchez, and J. M. Rho Molecular Biology and Ontogeny of Glutamate Receptors in the Mammalian Central Nervous System J Child Neurol, May 1, 2004; 19(5): 343 - 360. [Abstract] [PDF]
|
|
|
|
|
|
P. Malherbe, V. Mutel, C. Broger, F. Perin-Dureau, J. A. Kemp, J. Neyton, P. Paoletti, and J. N. C. Kew Identification of Critical Residues in the Amino Terminal Domain of the Human NR2B Subunit Involved in the RO 25-6981 Binding Pocket J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 897 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Foucaud, B. Laube, R. Schemm, A. Kreimeyer, M. Goeldner, and H. Betz Structural Model of the N-Methyl-D-aspartate Receptor Glycine Site Probed by Site-directed Chemical Coupling J. Biol. Chem., June 20, 2003; 278(26): 24011 - 24017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ren, Y. Honse, B. J. Karp, R. H. Lipsky, and R. W. Peoples A Site in the Fourth Membrane-associated Domain of the N-Methyl-D-aspartate Receptor Regulates Desensitization and Ion Channel Gating J. Biol. Chem., January 3, 2003; 278(1): 276 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gill, A. Alanine, A. Bourson, B. Buttelmann, G. Fischer, M.-P. Heitz, J. N. C. Kew, B. Levet-Trafit, H.-P. Lorez, P. Malherbe, et al. Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-D-Aspartate Antagonist J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 940 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Ballard, M. Pauly-Evers, G. A. Higgins, A.-M. Ouagazzal, V. Mutel, E. Borroni, J. A. Kemp, H. Bluethmann, and J. N. C. Kew Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity J. Neurosci., August 1, 2002; 22(15): 6713 - 6723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-B. Choi, H.-S. V. Chen, and S. A. Lipton Three Pairs of Cysteine Residues Mediate Both Redox and Zn2+ Modulation of the NMDA Receptor J. Neurosci., January 15, 2001; 21(2): 392 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. C. Kew, A. Koester, J.-L. Moreau, F. Jenck, A.-M. Ouagazzal, V. Mutel, J. G. Richards, G. Trube, G. Fischer, A. Montkowski, et al. Functional Consequences of Reduction in NMDA Receptor Glycine Affinity in Mice Carrying Targeted Point Mutations in the Glycine Binding Site J. Neurosci., June 1, 2000; 20(11): 4037 - 4049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. During, C. W. Symes, P. A. Lawlor, J. Lin, J. Dunning, H. L. Fitzsimons, D. Poulsen, P. Leone, R. Xu, B. L. Dicker, et al. An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and Epilepsy Science, February 25, 2000; 287(5457): 1453 - 1460. [Abstract] [Full Text]
|
|
|
|
|
|
Z. G. Wo, K. K. Chohan, H. Chen, M. J. Sutcliffe, and R. E. Oswald Cysteine Mutagenesis and Homology Modeling of the Ligand-binding Site of a Kainate-binding Protein J. Biol. Chem., December 24, 1999; 274(52): 37210 - 37218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969. [Abstract] [Full Text]
|
|
|
|
|
|
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Danysz and C. G. Parsons Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bottai, L. Maler, and R. J. Dunn Alternative RNA Splicing of the NMDA Receptor NR1 mRNA in the Neurons of the Teleost Electrosensory System J. Neurosci., July 15, 1998; 18(14): 5191 - 5202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Honer, D. Benke, B. Laube, J. Kuhse, R. Heckendorn, H. Allgeier, C. Angst, H. Monyer, P. H. Seeburg, H. Betz, et al. Differentiation of Glycine Antagonist Sites of N-Methyl-D-aspartate Receptor Subtypes. PREFERENTIAL INTERACTION OF CGP 61594 WITH NR1/2B RECEPTORS J. Biol. Chem., May 1, 1998; 273(18): 11158 - 11163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Laube, J. Kuhse, and H. Betz Evidence for a Tetrameric Structure of Recombinant NMDA Receptors J. Neurosci., April 15, 1998; 18(8): 2954 - 2961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Anson, P. E. Chen, D. J. A. Wyllie, D. Colquhoun, and R. Schoepfer Identification of Amino Acid Residues of the NR2A Subunit That Control Glutamate Potency in Recombinant NR1/NR2A NMDA Receptors J. Neurosci., January 15, 1998; 18(2): 581 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gallagher, H. Huang, E. R. Grant, and D. R. Lynch The NR2B-specific Interactions of Polyamines and Protons with the N-Methyl-D-aspartate Receptor J. Biol. Chem., October 3, 1997; 272(40): 24971 - 24979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Wood, H. M.A. VanDongen, and A. M.J. VanDongen An Alanine Residue in the M3-M4 Linker Lines the Glycine Binding Pocket of the N-Methyl-D-aspartate Receptor J. Biol. Chem., February 7, 1997; 272(6): 3532 - 3537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gallagher, H. Huang, D. B. Pritchett, and D. R. Lynch Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor J. Biol. Chem., April 19, 1996; 271(16): 9603 - 9611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Meddows, B. Le Bourdelles, S. Grimwood, K. Wafford, S. Sandhu, P. Whiting, and R. A. J. McIlhinney Identification of Molecular Determinants That Are Important in the Assembly of N-Methyl-D-aspartate Receptors J. Biol. Chem., May 25, 2001; 276(22): 18795 - 18803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abele, K. Keinanen, and D. R. Madden Agonist-induced Isomerization in a Glutamate Receptor Ligand-binding Domain. A KINETIC AND MUTAGENETIC ANALYSIS J. Biol. Chem., July 7, 2000; 275(28): 21355 - 21363. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
